Adagene Company
Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.
Founded Date:
2011-01-01
Total Funding:
155000000.0
Funding Status:
IPO
Last Funding Type:
Post-IPO Equity
Investors Number:
11.0
Last Funding Date:
2021-02-11
Industry:
End-to-End Drug Development
Headquarters:
Suzhou, Jiangsu, China
Estimated Revenue:
$1M to $10M